MARKET NEWS

Prothena Receives FDA Fast Track Designation for Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease
GeoVax Announces Issuance of Malaria Vaccine Patent
Editas Medicine Receives FDA Rare Pediatric Disease Designation for the Treatment of Beta Thalassemia
Catalent Acquires Commercial-Scale Cell Therapy Development & Manufacturing Facility From Erytech  
Starton Therapeutics Doses First Subjects in Phase 1 Clinical Trial of STAR-LLD Continuous Delivery Lenalidomide
Priothera Receives FDA Clearance of IND to start Phase 2b/3 Study With Mocravimod in AML Patients Undergoing Allogeneic HSCT

  FEATURED EDITORIAL

  COMPANY PROFILE

Serán Bioscience is a science-first CDMO, recognized as a leader in materials science, formulation development, and pharmaceutical manufacturing. We utilize a foundation of physical and chemical science to design robust formulations and engineered solutions. Our science, quality systems, regulatory expertise, and customer service are second to none. Your drug is your future, and you need a CMC partner that’s as committed to your success as you are. Click here for more.

Jubilant HollisterStier is an integrated contract manufacturer of sterile injectables, ophthalmics, otics and sterile and non-sterile topicals and liquids. Our facilities in North America provide specialized manufacturing for the pharmaceutical and biopharmaceutical industries. We provide a full-range of support and services to streamline the manufacturing process such as on-site assistance from process qualifications through product release. With over 100 years of manufacturing expertise with a global reach, our team is committed to meeting your project’s milestones efficiently. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Caladrius Biosciences & Cend Therapeutics Announce Definitive Merger Agreement

Caladrius Biosciences & Cend Therapeutics Announce Definitive Merger Agreement

Caladrius Biosciences, Inc. and Cend Therapeutics, Inc. recently announced the companies have entered into a definitive merger agreement under which Cend will merge with a wholly owned subsidiary of….

Symeres Acquires Organix, Adding Lipids Expertise & Strategic Foothold in the US

Symeres Acquires Organix, Adding Lipids Expertise & Strategic Foothold in the US

Symeres recently announced the acquisition of Organix Inc., a US-based specialized organic chemistry services provider with a focus on lipids…..

SOTIO Initiates CLAUDIO-01 Trial With Antibody-Drug Conjugate SOT102 in Patients With Gastric & Pancreatic Cancer

SOTIO Initiates CLAUDIO-01 Trial With Antibody-Drug Conjugate SOT102 in Patients With Gastric & Pancreatic Cancer

SOTIO Biotech recently announced it has dosed the first patient in its Phase 1/2 CLAUDIO-01 trial of SOT102 in patients with gastric and pancreatic cancer. SOT102 is the lead program of….

First European Union Patient Dosed With 177Lu-PNT2002 in the Phase 3 SPLASH Trial

First European Union Patient Dosed With 177Lu-PNT2002 in the Phase 3 SPLASH Trial

POINT Biopharma Global Inc. recently announced the first patient in the European Union (EU) has been dosed in the Phase 3 SPLASH trial (NCT04647526). The SPLASH trial….

  WHITEPAPERS & WEBINARS

On Demand Webinar – Emergent CDMO: High-Speed Manufacturing Solutions for Your Viral Vaccine or Therapeutic

On Demand Webinar – Emergent CDMO: High-Speed Manufacturing Solutions for Your Viral Vaccine or Therapeutic

Emergent and groniger partner to present the benefits and features of the INTEGRA® high-speed aseptic fill line with isolator technology for viral vaccines and therapeutics.

WEBINAR - ILC Dover: Handling Potent Products in a Sterile Environment

WEBINAR - ILC Dover: Handling Potent Products in a Sterile Environment

The need for flexible solutions for potent product handling is increasing. We’ll discuss the proven benefits of aseptic isolator systems in sterile environments and take a look at real feedback from real customers of ours in an upcoming webinar on Tuesday, November 16th at 11:00 AM EST.

  WHITEPAPERS & WEBINARS

WHITE PAPER - Making Sub-Visible Particles Visible: Innovative Analytical Techniques for Detection & Identification

WHITE PAPER - Making Sub-Visible Particles Visible: Innovative Analytical Techniques for Detection & Identification

The demand for complex, often life-saving drug substances such as monoclonal antibodies, interferons, and peptides is on the rise, creating a greater need for innovative delivery mechanisms to administer these new therapeutics. For a variety of reasons, sub-visible particles can …

WHITE PAPER - Poloxamer: A Simple & Powerful Solution for Accelerating Dissolution

WHITE PAPER - Poloxamer: A Simple & Powerful Solution for Accelerating Dissolution

Absorption of molecules from the gastrointestinal tract is an essential consideration when developing orally delivered medications. Solubility, the concentration of drug in solution, is essential for this to occur and it is important to also consider the dissolution rate of …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

May 11 – Particle Design Technology
May 18 – Nasal Drug Delivery